US Financial Controller

Harper May is partnering with a UK-headquartered, clinical-stage life sciences business based in central London. The business has developed a differentiated therapeutic platform and is now progressing through a critical phase of clinical development, alongside continued investor engagement and the build-out of its US operating footprint. With a growing US subsidiary already established and further scale-up planned, the finance function is now be...